Skin appendage disorders · 2018
Subclinical Onychomycosis: Not Present in HIV-Positive Population?
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Contreras-Rivera Claudia, Toussaint-Caire Sonia, Fernández-Martínez Ramón, Moreno-Coutiño Gabriela
Аннотация
BACKGROUND: Onychomycosis is one of the most common nail diseases and constitutes up to 50% of all nail conditions. It is a chronic fungal nail infection common in the HIV-infected population. Few studies have found fungal organisms in the nail without clinical evidence, and thus, termed subclinical onychomycosis.
OBJECTIVES: We analyzed the nails of the HIV population in our hospital, searching for subclinical onychomycosis.
METHOD: A distal nail clipping was stained with PAS and observed by a trained dermatopathologist.
RESULTS: All of our samples (n = 48) turned out to be negative for fungal structures.
CONCLUSIONS: The epidemiology of onychomycosis is changing, treatment options are much better now, and diagnosis and infection detection are being done earlier. Therefore, we will continue to further study this disease in other patient populations so that we can compare our results and see whether the incidence of onychomycosis in the HIV population is now similar to that in those without HIV infection of the same age.
OBJECTIVES: We analyzed the nails of the HIV population in our hospital, searching for subclinical onychomycosis.
METHOD: A distal nail clipping was stained with PAS and observed by a trained dermatopathologist.
RESULTS: All of our samples (n = 48) turned out to be negative for fungal structures.
CONCLUSIONS: The epidemiology of onychomycosis is changing, treatment options are much better now, and diagnosis and infection detection are being done earlier. Therefore, we will continue to further study this disease in other patient populations so that we can compare our results and see whether the incidence of onychomycosis in the HIV population is now similar to that in those without HIV infection of the same age.